The Global Folic Acid market is poised to reach a value of USD 627.5 million in 2024, and further expand at a CAGR of 4.8% to reach USD 1,233.2 million by the year 2034.
The world demand for folic acid is growing steadily, because people are becoming more aware of its health benefits and can be used in numerous places. Governments have ordered food fortification with the product to prevent neural tube defects during pregnancy.
This factor together with increasing population awareness concerning health issues accounts for high demand in various segments such as nutraceuticals, pharmaceuticals, and foods among others.
The competition in this industry is led by both local companies and international corporations that stimulate innovation. The industry’s future seems bright due to improved bioavailability, drug delivery systems and a shift towards prevention medicine as well as maternal health thus pushing demand higher.
| Attributes | Description |
|---|---|
| Estimated Global Folic Acid Industry Size (2024E) | USD 771.7 million |
| Projected Global Folic Acid Value (2034F) | USD 1,233.2 million |
| Value-based CAGR (2024 to 2034) | CAGR 4.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The table below presents a comparative assessment of the variation in CAGR over six months for the base year (2023) and current year (2024) for the Global Folic Acid industry.
This analysis reveals crucial shifts in industry performance and indicates revenue realization patterns, thus providing stakeholders with a better vision of the ecosystem growth trajectory over the year. The first half of the year, or H1, spans from January to June. The second half, H2, includes the months from July to December.
| Particular | Value CAGR |
|---|---|
| H1 | 5.4% (2023 to 2033) |
| H2 | 4.6% (2023 to 2033) |
| H1 | 4.4% (2024 to 2034) |
| H2 | 5.0% (2024 to 2034) |
The above table presents the expected CAGR for the global Folic Acid industry over several semi-annual periods spanning from 2024 to 2034. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 5.4%, followed by a slightly higher growth rate of 4.6% in the second half (H2) of the same decade.
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to increase slightly to 4.4% in the first half and remain relatively moderate at 5.0% in the second half.
Increased Fortification of Food Products
There is an increasing trend globally to fortify foods with folic acid. Folate deficiency can be combated effectively when cereals, bread, rice and other staple foods contain folic acid as recommended by governments and health agencies. This has a significant impact on public health since it also increases the demand for folic acid in the food sector.
As consumers become more knowledgeable about the advantages of fortified foods manufacturers prefer to add folic acid into their products so as to meet regulations and address buyer's concerns over a healthy diet.
Rising Popularity of Dietary Supplements
Folic acid is one of the components that drive rapid growth rates in dietary supplement industry globally. The present-day consumer seeks healthier lifestyles hence there is increased demand for tablets containing folic acid as supplements in prenatal care among others related to cardiovascular fitness and even generally healthy living.
Tablets, capsules or gummies make it simpler for users to take them up into their regular habits without much difficulty. For instance, there will always be people who look for ways through which they could improve their health using other means apart from eating healthy and hence, this trend keeps rising.
Advancements in Bioavailability and Delivery Methods
Industry trends show that innovations on how best folate dietary supplements can be consumed are what matters most. As a matter of fact, scientists and researchers are developing folic acid formulations that are being created to enhance its absorption and use in the body.
Among these are more bioavailable forms such as L-methylfolate, chewable tablets and liquid supplements that have been developed with better techniques. Nowadays these changes contribute to making folic acid more effective while at the same time considering different consumer choices thereby facilitating people's nutritional requirements.
Principal Consultant
Global Folic Acid sales increased at a CAGR of 3.7% from 2019 to 2023. For the next ten years (2024 to 2034), projections are that the Folic Acid landscape will rise at a forecasted CAGR of 4.8%.
The global folic acid landscape has seen significant growth over the past few decades because there is increased awareness of health benefits from it and where it can be used. The industry has grown fast due to increased recognition of the role played by folic acid in preventing neural tube defects during pregnancy thus many governments have ordered for food fortification.
In both developed and developing countries, this regulatory support coupled with an increasing consumer health consciousness has pushed demand for folic acid. In other instances like the pharmaceutical industry, folate deficiency diseases including treatments have made folic acid popular hence driving up its demand in worldwide.
This landscape has also been expanded by the nutraceutical sector through dietary supplements aimed at improving health status among people using them that generally contain folic acid as one of their key ingredients.
On the other hand, there are good indicators that the global folic acid sector will grow in the future. Demand is expected to be driven by a continued shift towards preventive healthcare and an increasing acceptance of dietary supplements.
The efficacy of folic acid as well as its capacity to serve a wider segment of customers could be improved through innovations in product formulations such as the development of more bioavailable forms of folic acid.
Moreover, emerging economies’ growing concern regarding maternal health opens doors for growth. Folic acid consumption is projected to increase with the implementation of food fortification programs and other nutritional interventions targeting malnutrition in certain countries. Finally, market expansion may also be fuelled by improvements in biotechnology and greater use of folic acid in functional foods and beverages.
The folic acid market is moderately fragmented with the presence of both MNCs and regional players. This kind of arrangement leads to diverse products and competitive pricing which are good for customers.
In a fragmented environment, there is no single dominant firm as many small to medium-sized firms operate in it which results into high-level competition and invention. The folic acid sector exhibits these traits, with many companies offering different formulations and delivery methods that satisfy the needs of various consumers.
Alternatively, in a consolidated environment, few large companies dominate leading to less competition but possibly higher prices and less innovation. The huge distribution networks and strong brand recognition held by some big MNCs such as DSM N.V. and BASF SE have made them have significant shares of the folic acid landscape.
Multinational corporations such as Pfizer Inc. or Merck KGaA in the field of folic acid can benefit from their global reach by achieving economies of scale that assure wide product availability across all sectors with consistent quality standards maintained throughout their production process habits. Therefore, they usually engage in extensive research programs that develop highly innovative products or new composition types.
On the other hand, smaller local businesses like Emcure Pharmaceuticals Ltd. from India or Hebei Jiheng Pharmaceutical Co., Ltd. from China concentrate primarily on national landscape, where they possess a deep understanding regarding consumer preferences at regional levels and regulatory policies making them competent enough to challenge established multinationals.
The moderately fragmented nature of the folic acid industry encourages competition and fosters innovation; thus having mixtures of MNCs as well as regional manufacturers enhances its dynamism, allowing wide range price levels with varied goods available to consumers globally.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The following table shows the estimated growth rates of the top industries. The USA and UK are set to exhibit high Folic Acid consumption, recording CAGRs of 4.2% and 2.8%, respectively, through 2034.
| Countries | CAGR 2024 to 2034 |
|---|---|
| USA | 4.2% |
| UK | 2.8% |
| China | 5.3% |
| India | 5.9% |
| Australia | 3.1% |
Widespread awareness of its health benefits and strong regulatory support for folic acid fortification in food products have led to the United States maintaining high consumption levels of the vitamin. Certain staple foods, including cereals and breads, are mandated by the government to have folic acid added to them as a preventive measure against neural tube defects.
In addition, the USA robust pharmaceutical and nutraceutical sectors ensure a constant supply of dietary supplement capsules containing folic acid.
Folic acid has many health-conscious consumers who also serve as healthcare providers hence contributing to its high consumption rates among different groups in society. The USA landscape is projected to grow at a CAGR of 4.6% from 2024 to 2034 and reach a value of USD 321..9 million or a value of 26.1% in 2034.
The German market for folic acid has grown over the years and is one of the largest markets in the world due to a health-conscious population and well-established healthcare infrastructure. The German customers prefer preventive healthcare and are well conversant with vitamins as well as supplements such as folic acid. This situation is fostered by Germany's regulatory environment which supports food fortification and high-quality supplementation products.
Additionally, because of these strong pharmaceutical and nutraceutical industries, Germany ensures that there are various brands of folic acid available to its consumers. Hence, through a combination of informed consumer behaviour and industry support, Germany leads in sales of folic acid. The industry is projected to have a world value share of 11.4% in 2034 with a value of USD 140.6 million owing to growth at a forecast CAGR of 3.8% from 2024 to 2034.
Knowing that China has a large population and increased consciousness about personal health is making more and more manufacturers venture into it. This trend is being driven by rising demand for vitamins/supplements including folic acid among Chinese consumers who have become more health conscious. Companies have started introducing other forms of folic acid like fortified foods that suit this trend as evident from their product lines.
To be successful in entering this market, strategic alliances with local firms must be made to comply with the set regulatory standards. Furthermore, creating awareness about the need for vital minerals such as iron can also increase consumer adoption rates thus making China a significant target for these firms. The Chinese landscape is projected to advance with a forecast CAGR of 5.5% from 2024 to 2034 to reach a value of USD 213.3 million in 2034.
| Segment | Food |
|---|---|
| Main segment | Application Type |
| Value Share (2024) | 24.7% |
Currently, there is an increasing use of food fortified with folate as supplements. It is based on the growing number of customers appreciating the benefits accrued from consuming the additional amount of folic acid, particularly during the pregnancy period; while some others may enhance specific health conditions naturally.
As a result, food producers are responding by bolstering different commodities including cereals breads and beverages by fortifying them with folic acid. Consequently, besides boosting the nutrient value in such foods; it offers people an easier alternative for meeting total consumption needs which can lead to better public health effects.
These reasons have led to Food application gaining a projected value share of 24.7% in 2034 with a value of USD 304. 6 million owing to a forecast CAGR of 6.3%.
| Segment | Tablets |
|---|---|
| Main segment | Form |
| Value Share (2024) | 76.4% |
Tablets are still the most commonly used form to consume folic acid because they are easy to use, have accurate dosage and can be stored easily. They are also widely available and hence can fit in the daily routines of different consumers. Besides this, tablets have a longer life span as compared to other forms thus ensuring that folic acid remains active for a long time.
Moreover, slow-release tablets enhance the absorption and effectiveness. This is evident from the market where tablet sales continue to dominate due to their practicality and reliability when it comes to delivering nutrient requirements. Folic Acid Tablets are projected to grow with a forecast CAGR of 4.4% from 2024 to 2034, which will help it reach a value of USD 942.2 million or a value share of 76.4% in 2034.
The worldwide market for folic acid is highly competitive with top players adopting various strategies to maintain their positions or gain more market share. Some of those strategies include mergers & acquisitions which enable companies expand product portfolios as well as geographical presence.
For instance, larger pharmaceutical firms often acquire smaller, innovative companies to integrate advanced technologies and diversify their offerings. Additionally, new products are launched into the market every year.
These could be in the form of chewable tablets among others which come in handy during periods when one requires certain nutrients. Newer versions capture novel sections of the consumer industry whilst keeping older customers satisfied at all times.
Moreover, heavy investment in R&D aimed at enhancing product efficacy, safety and compliance with regulatory standards marks most firms’ commitment towards meeting these needs.
They engage in strategic alliances especially with research institutions and other industry players thereby boosting business growth. Also taking part in marketing such as advertising on health benefits coupled with establishing brand equity helps intensify customer perception about folic Acid.
As per Application Type, the industry is categorized into Pharmaceuticals, Nutraceuticals, Food, and Beverages.
As per Source, the industry is categorized into Plants and Animal.
As per Form, the industry is categorized into Soft gels, Lozenges, and Tablets.
As per Distribution Channel, the industry is categorized into Online and Offline.
Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.
The global Folic Acid market is estimated at a value of USD 771.7 million in 2024.
Sales of Folic Acid increased at 3.7% CAGR between 2019 and 2023.
BASF SE, DSM N.V., Jiangxi Tianxin Pharmaceutical Co. Ltd, Emcure Pharmaceuticals Ltd., Zydus Pharmaceuticals Ltd., Medicamen Biotech Ltd., and Hebei Jiheng Pharmaceutical Co., Ltd. are some of the leading players in this landscape.
The USA is projected to hold a revenue share of 26.1% over the forecast period.
China holds a 17.3% share of the global market for Folic Acid.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Analysis and Forecast 6.1. Application Type 6.2. Source 6.3. Form 6.4. Distribution Channel 7. Global Analysis and Forecast, By Application Type 7.1. Pharmaceuticals 7.2. Nutraceuticals 7.3. Food and Beverages 8. Global Analysis and Forecast, By Source 8.1. Plants 8.2. Animal 9. Global Analysis and Forecast, By Form 9.1. Soft gels 9.2. Lozenges 9.3. Tablets 10. Global Analysis and Forecast, By Distribution Channel 10.1. Online 10.2. Offline 11. Global Analysis and Forecast, By Region 11.1. North America 11.2. Latin America 11.3. Western Europe 11.4. Eastern Europe 11.5. Asia Pacific 11.6. East Asia 11.7. MEA 12. North America Sales Analysis and Forecast, by Key Segments and Countries 13. Latin America Sales Analysis and Forecast, by Key Segments and Countries 14. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 15. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 16. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries 17. East Asia Sales Analysis and Forecast, by Key Segments and Countries 18. MEA Sales Analysis and Forecast, by Key Segments and Countries 19. Sales Forecast by Application Type, Source, Form, and Distribution Channel for 30 Countries 20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 21. Company Profile 21.1. DSM N.V. 21.2. Jiangxi Tianxin Pharmaceutical Co. Ltd 21.3. Emcure Pharmaceuticals Ltd. 21.4. Zydus Pharmaceuticals Ltd. 21.5. Medicamen Biotech Ltd. 21.6. Hebei Jiheng Pharmaceutical Co., Ltd. 21.7. Hema Pharmaceuticals Pvt. Ltd. 21.8. Pfizer Inc. 21.9. Superior Supplement Manufacturing
Explore Food and Beverage Insights
View Reports
Folic Acid Market
